Increased burden and severity of metabolic syndrome and arterial stiffness in treatment-naïve HIV+ patients from Cameroon

Vascular Health and Risk Management

Volumn 9, Issue 1, 2013, Pages 509-516

  Ngatchou, William ^a   Lemogoum, Daniel ^a   Ndobo, Pierre ^b   Yagnigni, Euloge ^b   Tiogou, Emiline ^b   Nga, Elisabeth ^b   Kouanfack, Charles ^b   van de Borne, Philippe ^a   Hermans, Michel P ^c  

^a ERASME HOSPITAL   (Belgium)

^b YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Arterial; Cameroon; HIV; Metabolic syndrome; Stiffness

Indexed keywords

GLUCOSE; LIPID; TRIACYLGLYCEROL;

ADULT; ANKLE BRACHIAL INDEX; AORTIC AUGMENTATION RATE; ARTERIAL STIFFNESS; ARTICLE; ATHEROGENESIS; CAMEROON; CARDIOMETABOLIC RISK; CARDIOVASCULAR MONITORING DEVICE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PULSE WAVE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ARTERIAL; CAMEROON; HIV; METABOLIC SYNDROME; STIFFNESS;

ADULT; AORTIC DISEASES; ARTERIAL PRESSURE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CAMEROON; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PULSE WAVE ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR STIFFNESS;

EID: 84890031408     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S42350     Document Type: Article

References (42)

1. Sabin CA, Worm SW, Weber R, et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet. 2008;371(9622):1417-1426.
2. Barbaro G, Fisher SD, Lipshultz SE. Pathogenesis of HIV-associated cardiovascular complications. Lancet Infect Dis. 2001;1(2):115-124.
3. Dau B, Holodniy M. The relationship between HIV infection and cardiovascular disease. Curr Cardiol Rev. 2008;4(3):203-218.
4. Hsue PY, Lo JC, Franklin A, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004;109(13):1603-1608.
5. Glazier JJ, Spears JR, Murphy MC. Interventional approach to recurrent myocardial infarction in HIV-1 infection. J Interv Cardiol. 2006;19(1):93-98.
6. Ridder SA, Smit E, Cole SR, et al. Impact of HIV infection and HAART on serum lipid in men. JAMA. 2003;289(22):2978-2982.
7. Shahmanesh M, Das S, Stolinski M, et al. Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia. J Clin Endocrinol Metab. 2005;90(2):755-760.
8. Mujawar Z, Rose H, Morrow MP, et al. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. Plos Biol. 2006;4(11):e365.
9. Freitas P, Carvalho D, Souto S, et al. Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients. BMC Infect Dis. 2011;11:246.
10. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709-2716.
11. Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113(5):664-670.
12. Schillaci G, De Socio GV, Pucci G, et al. Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. Hypertension. 2008;52(2):308-313.
13. London GM, Blacher L, Pannier B, Guérin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38(3):434-438.
14. Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the Global HIV/AIDS Epidemic. Geneva, Switzerland: UNAIDS; 2008. Available from: http://www.unaids.org/globalreport/Global_report.htm. Accessed on October 12, 2010.
15. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105-1187.
16. Alberti KG, Eckel RH, Grundy SM, et al; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart 2009;120(16):1640-1645.
17. Hermans MP, Ahn SA, Rousseau MF. log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males. Cardiovasc Diabetol. 2010;9:88.
18. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension. 1995;26(3):485-490.
19. Lemogoum D, Van Bortel L, Najem B, et al. Arterial stiffness and wave reflections in patients with sickle cell disease. Hypertension. 2004;44(6):924-929.
20. Wilkinson IB, Fuchs SA, Jansen IM, et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens. 1998;16(12 Pt 2):2079-2084.
21. Lazar JM, Wu Xi, Shi Q, et al. Arterial wave reflection in HIV-infected and HIV-uninfected Rwandan women. AIDS Res Hum Retroviruses. 2009;25(9):877-882.
22. Fourie C, Van Rooyen J, Pieters M, Conradie K, Hoekstra T, Schutte A. Is HIV-1 infection associated with endothelial dysfunction in a population of African ancestry in South Africa? Cardiovasc J Afr. 2011;22(3):134-140.
23. Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N. Hypertension prevalence, awareness, treatment, and control in Mozambique: urban/rural gap during epidemiological transition. Hypertension. 2009;54(1):77-83.
24. Mufunda J, Chatora R, Ndambakuwa Y, et al. Emerging non-communicable disease epidemic in Africa: preventive measures from the WHO Regional Office for Africa. Ethn Dis. 2006;16(2):521-526.
25. Bloomfield GS, Hogan JW, Keter A, et al. Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PloS One. 2011;6(7):e22288.
26. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens. 2009;23(6):363-384.
27. He FJ, Marciniak M, Visagie E, et al. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension. 2009;54(3):482-488.
28. Womack J. HIV-related lipodystrophy in Africa and Asia. AIDS Read. 2009;19(4):131-139, 148-152.
29. Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res. 2006;98(11):1352-1364.
30. Patel S, Puranik R, Nakhla S, et al. Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. Atherosclerosis. 2009;204(2):424-428.
31. Yoshida M, Mita T, Yamamoto R, et al. Combination of Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes. Diabetes Care. 2012;35(1):178-180.
32. Grinspoon S. Insulin resistance in the HIV-lipodystrophy syndrome. Trends Endocrinol Metab. 2001;12(9):413-419.
33. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24(4):683-689.
34. Aberg JA. Cardiovascular complications in HIV management: past, present, and future. J Acquir Immune Defic Syndr. 2009;50(1): 54-64.
35. Garrido RA, Semeraro MB, Temesgen SM, Simi MR. Metabolic syndrome and obesity among workers at Kanye Seventh-Day Adventist Hospital, Botswana. South Afr Med J. 2009;99(5):331-334.
36. Mondy K, Overton ET, Grubb J, et al. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clin Infec Dis. 2007;44(5):726-734.
37. Bonfati P, Giannattasio C, Ricci E, et al. HIV and metabolic syndrome: a comparison with the general population. J Acquir Immune Defic Syndr. 2007;45(4):426-431.
38. Lacy PS, O'Brien DG, Stanley AG, Dewar MM, Swales PP, Williams B. Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J Hypertens. 2004;22(10):1937-1944.
39. Vyas M, Izzo JL Jr, Lacourcière Y, et al. Augmentation index and central aortic stiffness in middle-aged to elderly individuals. Am J Hypertens. 2007;20(6):642-647.
40. Lemogoum D, Flores G, Van den Abeele W, et al. Validity of pulse pressure and augmentation index as surrogate measures of arterial stiffness during beta-adrenergic stimulation. J Hypertens. 2004;22(3): 511-517.
41. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352(1):48-62.
42. Katchunga PB, Hermans M, Bamuleke BA, Katoto PC, Kabinda JM. Relationship between waist circumference, visceral fat and metabolic syndrome in a Congolese community: further research is still to be undertaken. Pan Afr Med J. 2013;14:20.